Finacea and Finacea Foam (Azelaic Acid 15%)

One of the best known topicals to treat the papules and pustules of rosacea is Finacea. Finacea is Azelaic Acid 15%. Finacea is only available on prescription in the US but is available over the counter in Australia. Be sure to check out the Finacea User Reviews and also the recently approved Finacea Foam product.

Recent Rosacea Blog Posts

Galderma is staking out its claim on potential rosacea topicals with another patent being published. This patent details potential topicals that are combinations of the active ingredients in Sansrosa and Finacea, namely Brimonidine Tartrate and Azelaic Acid. The touted benefits from combining the two actives is a reduction in rebound redness and a greater tolerance […]

Continue Reading

Solodyn with and without Finacea

A recent study has highlighted the benefits of the combination therapy of Solodyn and Finacea. Solodyn is one of the lesser known systemic rosacea treatments. What is Solodyn? Solodyn is an extended-release, low dosage of Minocycline, a member of the tetracycline family. Solodyn is available in 8 strengths. Yes that is right you can get […]

Continue Reading

Generic Finacea sees Bayer suing Glenmark

Bayer AG, owner of Intendis who make Finacea, has sued Mumbai, India’s Glenmark Generics Ltd., seeking to stop sales of a generic form of it’s Finacea gel. Bayer is Germany’s largest drugmaker. Glenmark Pharmaceuticals, a maker of generics, triggered this defensive legal move from Bayer by filing a Abbreviated New Drug Application (ANDA) for a generic […]

Continue Reading

Large Rosacea Foam Study Wants US Participants

A large clinical study is looking for rosacea sufferers with the papules and pustules of rosacea. The study, called Rosetta, is looking for up to 960 participants for 40 locations across the US. The study will require up to 6 visits over 16 – 17 weeks. Study Publicity Following is the official promotional text for […]

Continue Reading

Comparing Sansrosa to Finacea for Redness

Galderma are surely confirming that the development of Sansrosa 0.5% Gel (CD07805/47) is nearing completion, with the posting of a proposed comparison trial with Finacea. The trial NCT01659853 will compare how effective Sansrosa is compared to Finacea. The primary outcome will be to assess, after 15 days, an improvement in facial redness. The secondary outcome […]

Continue Reading



Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.